Xiaoyan Yin, MBBS

Shandong Cancer Hospital Affiliated to Shandong First Medical University
Jinan, Shandong

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2181 - The Efficacy and Safety of TQB2450 Combined with Anlotinib as Maintenance Therapy for LS-SCLC after Definitive Concurrent or Sequential Chemoradiotherapy: A Prospective Phase Ib Study

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET

• 2182 - CT-Based Radiomics Model Predicts Occult Lymph Node Metastasis in Patients with Early-Stage Lung Adenocarcinoma: A Multicenter Study

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET

• 2184 - Predicting Micropapillary or Solid Pattern of Early-Stage Lung Adenocarcinoma with CT-Based Radiomics: A Multicenter Study

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET